These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Diagnostic value of brain MRI and 18F-FDG PET in the differentiation of Parkinsonian-type multiple system atrophy from Parkinson's disease. Kwon KY; Choi CG; Kim JS; Lee MC; Chung SJ Eur J Neurol; 2008 Oct; 15(10):1043-9. PubMed ID: 18717730 [TBL] [Abstract][Full Text] [Related]
24. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Schulz JB; Skalej M; Wedekind D; Luft AR; Abele M; Voigt K; Dichgans J; Klockgether T Ann Neurol; 1999 Jan; 45(1):65-74. PubMed ID: 9894879 [TBL] [Abstract][Full Text] [Related]
25. Assessing disease progression with MRI in atypical parkinsonian disorders. Köllensperger M; Wenning GK Mov Disord; 2009; 24 Suppl 2():S699-702. PubMed ID: 19877233 [TBL] [Abstract][Full Text] [Related]
26. The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy. Baudrexel S; Seifried C; Penndorf B; Klein JC; Middendorp M; Steinmetz H; Grünwald F; Hilker R Mov Disord; 2014 Mar; 29(3):380-7. PubMed ID: 24243813 [TBL] [Abstract][Full Text] [Related]
27. Diffusion weighted imaging best discriminates PD from MSA-P: A comparison with tilt table testing and heart MIBG scintigraphy. Köllensperger M; Seppi K; Liener C; Boesch S; Heute D; Mair KJ; Mueller J; Sawires M; Scherfler C; Schocke MF; Donnemilier E; Virgolini I; Wenning GK; Poewe W Mov Disord; 2007 Sep; 22(12):1771-6. PubMed ID: 17579357 [TBL] [Abstract][Full Text] [Related]
28. The difference in putamen volume between MSA and PD: evidence from a meta-analysis. Sako W; Murakami N; Izumi Y; Kaji R Parkinsonism Relat Disord; 2014 Aug; 20(8):873-7. PubMed ID: 24844749 [TBL] [Abstract][Full Text] [Related]
29. The contribution of cerebellar proton magnetic resonance spectroscopy in the differential diagnosis among parkinsonian syndromes. Zanigni S; Testa C; Calandra-Buonaura G; Sambati L; Guarino M; Gabellini A; Evangelisti S; Cortelli P; Lodi R; Tonon C Parkinsonism Relat Disord; 2015 Aug; 21(8):929-37. PubMed ID: 26077167 [TBL] [Abstract][Full Text] [Related]
30. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease. Schocke MF; Seppi K; Esterhammer R; Kremser C; Mair KJ; Czermak BV; Jaschke W; Poewe W; Wenning GK Neuroimage; 2004 Apr; 21(4):1443-51. PubMed ID: 15050569 [TBL] [Abstract][Full Text] [Related]
31. The role of neuroimaging in the diagnosis of the atypical parkinsonian syndromes in clinical practice. Dąbrowska M; Schinwelski M; Sitek EJ; Muraszko-Klaudel A; Brockhuis B; Jamrozik Z; Sławek J Neurol Neurochir Pol; 2015; 49(6):421-31. PubMed ID: 26652877 [TBL] [Abstract][Full Text] [Related]
33. Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy. Hussl A; Mahlknecht P; Scherfler C; Esterhammer R; Schocke M; Poewe W; Seppi K Mov Disord; 2010 Oct; 25(14):2444-9. PubMed ID: 20878992 [TBL] [Abstract][Full Text] [Related]
34. Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD. Yekhlef F; Ballan G; Macia F; Delmer O; Sourgen C; Tison F J Neural Transm (Vienna); 2003 Feb; 110(2):151-69. PubMed ID: 12589575 [TBL] [Abstract][Full Text] [Related]
35. [Phase-weighted imaging in differentiating multiple system atrophy from idiopathic Parkinson disease]. Feng F; You H; Wang H; Zheng FL; Jin ZY; Cui LY Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):129-33. PubMed ID: 19507587 [TBL] [Abstract][Full Text] [Related]
36. Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging. Savoiardo M Neurol Sci; 2003 May; 24 Suppl 1():S35-7. PubMed ID: 12774211 [TBL] [Abstract][Full Text] [Related]
37. How to diagnose MSA early: the role of sphincter EMG. Vodusek DB J Neural Transm (Vienna); 2005 Dec; 112(12):1657-68. PubMed ID: 16284909 [TBL] [Abstract][Full Text] [Related]
38. [Differentiation of atypical Parkinson syndrome and delineation from idiopathic Parkinson syndrome with routine magnetic resonance tomography]. Csoti I; Warmuth-Metz M; Solymosi L; Becker Dagger G; Fornadi F; Naumann M Nervenarzt; 2004 Feb; 75(2):128-34. PubMed ID: 14770282 [TBL] [Abstract][Full Text] [Related]
39. Cardiovascular autonomic testing performed with a new integrated instrumental approach is useful in differentiating MSA-P from PD at an early stage. Baschieri F; Calandra-Buonaura G; Doria A; Mastrolilli F; Palareti A; Barletta G; Solieri L; Guaraldi P; Martinelli P; Cortelli P Parkinsonism Relat Disord; 2015 May; 21(5):477-82. PubMed ID: 25749354 [TBL] [Abstract][Full Text] [Related]
40. Putaminal hypointensity on T2*-weighted MR imaging is the most practically useful sign in diagnosing multiple system atrophy: A preliminary study. Sugiyama A; Ito S; Suichi T; Sakurai T; Mukai H; Yokota H; Yonezu T; Kuwabara S J Neurol Sci; 2015 Feb; 349(1-2):174-8. PubMed ID: 25619571 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]